Quick Answer
BIO-RAD LABORATORIES, INC. reported Net Income Loss of $759.90 million for the year ending 2025.
- BIO-RAD LABORATORIES, INC. showed an increase of +141.2% in Net Income Loss from 2024 to 2025.
- This data is from BIO-RAD LABORATORIES, INC.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $22.07 million | Q4 2017: $82.70 million | Q1 2018: $656.80 million | Q2 2018: $268.00 million | Q3 2018: $269.30 million | Q4 2018: -$828.50 million | Q1 2019: $865.20 million | Q2 2019: $598.80 million | Q3 2019: -$258.80 million | Q4 2019: $553.50 million | Q1 2020: $685.90 million | Q2 2020: $966.40 million | Q3 2020: $1.31 billion | Q4 2020: $839.20 million | Q1 2021: $980.00 million | Q2 2021: $916.80 million | Q3 2021: $3.93 billion | Q4 2021: -$1.57 billion | Q1 2022: -$3.37 billion | Q2 2022: -$925.10 million | Q3 2022: -$162.80 million | Q4 2022: $827.70 million | Q1 2023: $69.00 million | Q2 2023: -$1.16 billion | Q3 2023: $106.30 million | Q4 2023: $349.70 million | Q1 2024: $383.90 million | Q2 2024: -$2.17 billion | Q3 2024: $653.20 million | Q4 2024: -$715.80 million | Q1 2025: $64.00 million | Q2 2025: $317.80 million | Q3 2025: -$341.90 million.
- Over the full 18 years of available data (2008 to 2025), BIO-RAD LABORATORIES, INC.'s Net Income Loss has grown by 749.0%.
- Historical annual values: Fiscal year 2025: $759.90 million | Fiscal year 2024: -$1.84 billion | Fiscal year 2023: -$637.30 million | Fiscal year 2022: -$3.63 billion | Fiscal year 2021: $4.25 billion | Fiscal year 2020: $3.81 billion | Fiscal year 2019: $1.76 billion | Fiscal year 2018: $365.61 million | Fiscal year 2017: $122.25 million | Fiscal year 2016: $26.00 million | Fiscal year 2015: $109.24 million | Fiscal year 2014: $88.85 million | Fiscal year 2013: $77.79 million | Fiscal year 2012: $165.48 million | Fiscal year 2011: $179.01 million | Fiscal year 2010: $185.49 million | Fiscal year 2009: $144.62 million | Fiscal year 2008: $89.51 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: